Abiopharma

News list

Director Wright Kristopher 🟡 adjusted position in 0 shares (1 derivative) of LiveOne, Inc. (LVO) Transaction Date: Mar 31, 2026 | Filing ID: 039673

Full text

News bot April 3, 2026, 1:02 a.m.
🔍 Wright Kristopher (Director)

Company: LiveOne, Inc. (LVO)

Report Date: 2026-03-31
Transaction Summary:
- Total transactions: 2
- Derivative instruments: 1
- Holdings reported: 0
- Total shares acquired: 20,040
- Total shares sold: 20,040
Detailed Transactions and Holdings:
- Acquired 20,040 shares of Common Stock, $0.001 par value (Direct)
  Date: 2026-03-31 | Code: M | equity_swap_involved: 0 | shares_owned_after: 175,090.00 | transaction_form_type: 4 | Footnotes: F1
- Sold 20,040 shares of Restricted Stock Units (Derivative)
  Date: 2026-03-31 | Code: M | equity_swap_involved: 0 | transaction_form_type: 4 | Footnotes: F1, F2, F2
Footnotes:
- F1: Restricted Stock Units convert into the Issuer's common stock on a one-for-one basis.
- F2: Represents vested Restricted Stock Units (the "RSUs") that were settled on the reported date, which RSUs were previously granted to the Reporting Person as director fees for service on the Issuer's board of directors for the period from October 1, 2024 to September 30, 2025. Each vested RSU was settled by the Issuer by delivery to the Reporting Person of one share of Issuer's common stock.